Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
IM Cannabis Corp ( (IMCC) ) has provided an announcement.
IM Cannabis Corp. announced it is actively exploring strategic options to enter the United States cannabis market following a recent executive order from President Donald Trump directing the rescheduling of marijuana to recognize its medical benefits while maintaining federal oversight. To support this potential U.S. expansion and evaluate possible divestitures of its German and Israeli operations, the company has retained SSC Advisors as exclusive financial advisors to identify partners or acquirers and manage any related transactions, signaling a potential pivot in its geographic focus and capital allocation strategy that could reshape its operational footprint and market positioning.
The most recent analyst rating on (IMCC) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the IMCC Stock Forecast page.
Spark’s Take on IMCC Stock
According to Spark, TipRanks’ AI Analyst, IMCC is a Neutral.
The overall stock score is primarily impacted by the company’s weak financial performance, characterized by ongoing losses and negative cash flows. Technical analysis provides a slightly positive outlook due to short-term momentum, but valuation concerns due to a negative P/E ratio and lack of dividends weigh heavily. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on IMCC stock, click here.
More about IM Cannabis Corp
IM Cannabis Corp. is an international medical cannabis company listed on Nasdaq that supplies premium cannabis products to medical patients in Israel and Germany. It operates a transnational, data-driven ecosystem with a globally sourced supply chain, running import, distribution, pharmacies and online platforms in Israel, and distributing medical cannabis to pharmacies in Germany through its Adjupharm GmbH subsidiary, with a focus on compliant, high-quality products in tightly regulated markets.
Average Trading Volume: 558,144
Technical Sentiment Signal: Strong Sell
Current Market Cap: $7.5M
Find detailed analytics on IMCC stock on TipRanks’ Stock Analysis page.